Cyclin-dependent kinase 5 regulates degranulation in human eosinophils

Immunology

Volumn 144, Issue 4, 2015, Pages 641-648

  Odemuyiwa, Solomon O ^a,b   Ilarraza, Ramses ^a,c   Davoine, Francis ^a   Logan, Michael R ^a   Shayeganpour, Anooshirvan ^a   Wu, Yingqi ^b   Majaesic, Carina ^b   Adamko, Darryl J ^b   Moqbel, Redwan ^c   Lacy, Paige ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

SNARE; Cyclin dependent kinase 5; Degranulation; Granulocytes; Roscovitine

Indexed keywords

AT 7519; CYCLIN DEPENDENT KINASE 5; EOSINOPHIL PEROXIDASE; EOTAXIN; MUNC18C PROTEIN; PROTEIN; PROTEIN P35; PROTEIN P39; PROTEIN SERINE THREONINE KINASE INHIBITOR; ROSCOVITINE; SECRETORY IMMUNOGLOBULIN; SEPHAROSE; SMALL INTERFERING RNA; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; CDK5 ACTIVATOR P39; CDK5 PROTEIN, HUMAN; IMMUNOLOGIC FACTOR; MUNC18 PROTEIN; NERVE PROTEIN; NEURONAL CDK5 ACTIVATOR (P25-P35); PROTEIN BINDING; PROTEIN KINASE INHIBITOR;

ARTICLE; CELL ACTIVATION; CELL GRANULE; CONTROLLED STUDY; DEGRANULATION; ENZYME RELEASE; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HL-60 CELL LINE; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR;

CELL DEGRANULATION; CYCLIN-DEPENDENT KINASE 5; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EOSINOPHIL PEROXIDASE; EOSINOPHILS; HL-60 CELLS; HUMANS; IMMUNOLOGIC FACTORS; MUNC18 PROTEINS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84924351938     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12416     Document Type: Article

References (44)

1. Adamko D, Lacy P, Moqbel R. Eosinophil function in allergic inflammation: from bone marrow to tissue response. Curr Allergy Asthma Rep 2004; 4:149-58.
2. Ochkur SI, Jacobsen EA, Protheroe CA et al. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol 2007; 178:7879-89.
3. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22:789-815.
4. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38:709-50.
5. Stow JL, Manderson AP, Murray RZ. SNAREing immunity: the role of SNAREs in the immune system. Nat Rev Immunol 2006; 6:919-29.
6. Lacy P, Logan MR, Bablitz B, Moqbel R. Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-γ-induced piecemeal degranulation in human eosinophils from atopic individuals. J Allergy Clin Immunol 2001; 107:671-8.
7. Logan MR, Lacy P, Odemuyiwa SO, Steward M, Davoine F, Kita H, Moqbel R. A critical role for vesicle-associated membrane protein-7 in exocytosis from human eosinophils and neutrophils. Allergy 2006; 61:777-84.
8. Logan MR, Lacy P, Bablitz B, Moqbel R. Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane protein-2 in exocytosis. J Allergy Clin Immunol 2002; 109:299-306.
9. Lilja L, Yang SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C. Cyclin-dependent kinase 5 promotes insulin exocytosis. J Biol Chem 2001; 276:34199-205.
10. 2+-dependent exocytosis. J Biol Chem 2004; 279:29534-41.
11. Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28:2925-39.
12. Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol 2001; 2:749-59.
13. Dhariwala FA, Rajadhyaksha MS. An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol 2008; 28:351-69.
14. Rosales JL, Lee KY. Extraneuronal roles of cyclin-dependent kinase 5. BioEssays 2006; 28:1023-34.
15. Carr CM, Grote E, Munson M, Hughson FM, Novick PJ. Sec1p binds to SNARE complexes and concentrates at sites of secretion. J Cell Biol 1999; 146:333-44.
16. Wu MN, Littleton JT, Bhat MA, Prokop A, Bellen HJ. ROP, the Drosophila Sec1 homolog, interacts with syntaxin and regulates neurotransmitter release in a dosage-dependent manner. EMBO J 1998; 17:127-39.
17. Sassa T, Harada S, Ogawa H, Rand JB, Maruyama IN, Hosono R. Regulation of the UNC-18-Caenorhabditis elegans syntaxin complex by UNC-13. J Neurosci 1999; 19:4772-7.
18. Verhage M, Maia AS, Plomp JJ et al. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 2000; 287:864-9.
19. Yamaguchi T, Dulubova I, Min SW, Chen X, Rizo J, Sudhof TC. Sly1 binds to Golgi and ER syntaxins via a conserved N-terminal peptide motif. Dev Cell 2002; 2:295-305.
20. Latham CF, Meunier FA. Munc18a: Munc-y business in mediating exocytosis. Int J Biochem Cell Biol 2007; 39:1576-81.
21. Arunachalam L, Han L, Tassew NG, He Y, Wang L, Xie L et al. Munc18-1 is critical for plasma membrane localization of Syntaxin1 but not of SNAP-25 in PC12 cells. Mol Biol Cell 2008; 19:722-34.
22. Latham CF, Lopez JA, Hu SH et al. Molecular dissection of the Munc18c/syntaxin4 interaction: implications for regulation of membrane trafficking. Traffic 2006; 7:1408-19.
23. Toonen RF, Verhage M. Vesicle trafficking: pleasure and pain from SM genes. Trends Cell Biol 2003; 13:177-86.
24. Reed GL, Houng AK, Fitzgerald ML. Human platelets contain SNARE proteins and a Sec1p homologue that interacts with syntaxin 4 and is phosphorylated after thrombin activation: implications for platelet secretion. Blood 1999; 93:2617-26.
25. Chen F, Studzinski GP. Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood 2001; 97:3763-7.
26. Rosales JL, Ernst JD, Hallows J, Lee KY. GTP-dependent secretion from neutrophils is regulated by Cdk5. J Biol Chem 2004; 279:53932-6.
27. Odemuyiwa SO, Ghahary A, Li Y, Puttagunta L, Lee JE, Musat-Marcu S, Moqbel R. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2, 3-dioxygenase. J Immunol 2004; 173:5909-13.
28. Schlaepfer IR, Pulawa LK, Ferreira LD, James DE, Capell WH, Eckel RH. Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance. J Lipid Res 2003; 44:1174-81.
29. Fischkoff SA, Pollak A, Gleich GJ, Testa JR, Misawa S, Reber TJ. Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med 1984; 160:179-96.
30. Ishihara K, Hong J, Zee O, Ohuchi K. Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate. Int Arch Allergy Immunol 2005; 137(Suppl 1):77-82.
31. Adamko DJ, Wu Y, Gleich GJ, Lacy P, Moqbel R. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation. J Immunol Methods 2004; 291:101-8.
32. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997; 13:261-91.
33. Russo AA, Jeffrey PD, Pavletich NP. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat Struct Biol 1996; 3:696-700.
34. Wyatt PG, Woodhead AJ, Berdini V et al. Identification of N-(4-piperidinyl)-4-(2, 6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design. J Med Chem 2008; 51:4986-99.
35. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994; 371:423-6.
36. Sharma P, Sharma M, Amin ND, Albers RW, Pant HC. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc Natl Acad Sci USA 1999; 96:11156-60.
37. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000; 405:360-4.
38. Fletcher AI, Shuang R, Giovannucci DR, Zhang L, Bittner MA, Stuenkel EL. Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J Biol Chem 1999; 274:4027-35.
39. Duffin R, Leitch AE, Sheldrake TA et al. The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. FEBS Lett 2009; 583:2540-6.
40. Farahi N, Uller L, Juss JK et al. Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance. Clin Exp Allergy 2011; 41:673-87.
41. Wong CK, Lau KM, Chan IH, Hu S, Lam YY, Choi AO, Lam CW. MicroRNA-21* regulates the prosurvival effect of GM-CSF on human eosinophils. Immunobiology 2013; 218:255-62.
42. Ohyama H, McBride J, Wong DT. Optimized conditions for gene transfection into the human eosinophilic cell line EoL-1 by electroporation. J Immunol Methods 1998; 215:105-11.
43. Esnault S, Malter JS. Primary peripheral blood eosinophils rapidly degrade transfected granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 1999; 163:5228-34.
44. Whittaker SR, Te Poele RH, Chan F, Linardopoulos S, Walton MI, Garrett MD, Workman P. The cyclin-dependent kinase inhibitor seliciclib (R-roscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosis. Cell Cycle 2007; 6:3114-31.